home · filing · 0001628280-23-034229
8-K
filed October 11, 2023, 7:59 PM ET
ticker EPC
CIK 0001096752
leadership
confidence high
sentiment neutral
materiality 0.45
Edgewell names LaTanya Langley Chief People and Legal Officer; CHRO John Hill departing
EDGEWELL PERSONAL CARE Co
LaTanya Langley appointed Chief People and Legal Officer effective Nov 6, 2023, combining HR and Legal functions.
John Hill, CHRO, will depart Jan 5, 2024, after 25 years at Edgewell; entered separation agreement Oct 6, 2023.
Hill receives severance of 1.5x base salary plus 1.5x target FY2024 bonus, health premium, and transition bonus.
Hill will remain through calendar 2023 to transition responsibilities to Langley.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-01-05
Filed October 11, 2023, 7:59 PM ET
Mr. Hill’s separation from the Company will be effective January 5, 2024
Effective 2023-11-06
Filed October 11, 2023, 7:59 PM ET
will appoint LaTanya Langley to the new role of Chief People and Legal Officer effective as of that same date.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
John N. Hill departed as Chief Human Resources Officer at EDGEWELL PERSONAL CARE Co.
Action separation
Role Chief Human Resources Officer
Exact text from the filing
Mr. Hill’s separation from the Company will be effective January 5, 2024
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
LaTanya Langley was appointed as Chief People and Legal Officer at EDGEWELL PERSONAL CARE Co.
Action appointed
Role Chief People and Legal Officer
Exact text from the filing
will appoint LaTanya Langley to the new role of Chief People and Legal Officer effective as of that same date.
View on SEC.gov
Source: SEC EDGAR
accession 0001628280-23-034229
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.